中文
Press Release
Press Release
2025
2024
2023
2022
2021
2020
2019
2018
2017
Apr 02, 2025
Mabwell Announces NMPA Approval to Initiate Clinical Trial of novel B7-H3-targeting ADC for Advanced Solid Tumors in Combination with PD-1 Inhibitor

➞
Mar 27, 2025
Mabwell and Insilico Medicine Announce Strategic Collaboration to Empower R&D of ADC with AI

➞
Mar 26, 2025
Mabwell to Present results of 6 studies at the 2025 American Association for Cancer Research (AACR) Annual Meeting

➞
Feb 19, 2025
Mabwell publishes the preclinical research results of integrin-αvβ8-targeting antibody in the renowned journal

➞
Jan 09, 2025
Mabwell's Nectin-4 Targeted ADC 9MW2821 Combination Therapy Demonstrates 87.5% ORR and Granted CDE Breakthrough Therapy Designation

➞